Insmed has launched a first-in-human Phase 1 trial testing its experimental ALS gene therapy INS1202 in people with the disease.

Experimental therapy RT1999 will soon be tested in the UK EXPERTS-ALS platform trial designed to rapidly screen potential ALS treatments.

Johns Hopkins’s Center for Immunization Research is enrolling otherwise healthy medical subjects to be injected and infected with Zika, the virus associated with microcephaly that created a global ...